Study uncovers mechanisms underlying microglia-driven neuroinflammation in Alzheimer’s disease

A study by Brigham investigators revealed how genetic changes in certain types of brain cells may contribute to the inflammatory response seen in Alzheimer’s disease.

XRHealth Deploys VR Headsets in Israel to Assist Victims of Hamas Attacks

What You Should Know: – XRHealth today announced that they are currently deploying hundreds of VR headsets in Israel to treat patients coping with anxiety,

October 20, 2023

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights | Psychedelic Invest

NEW YORK and BERLIN, March 28, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”) a clinical-stage biopharmaceutical company aiming to transform the treatment

March 28, 2024

Eckert & Ziegler becomes European contract manufacturer for Telix’s innovative Phase III ProstACT GLOBAL study – Biotech Investments

EQS-News: Eckert & Ziegler SE / Key word(s): Contract/Alliance Eckert & Ziegler becomes European contract manufacturer for Telix’s innovative Phase III ProstACT GLOBAL study 13.08.2024

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.